Zobrazeno 1 - 9
of 9
pro vyhledávání: '"ICRU, International Commission on Radiation Units and Measurements"'
Autor:
Maud le Guyader, Daniel Lam Cham Kee, Mathieu Gautier, Marie-Eve Chand-Fouche, Renaud Schiappa, Brice Thamphya, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 15-23 (2022)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Brachytherapy boost is a standard of care for locally advanced cervical cancer. • High-dose-rate brachytherapy (HDR-BT) boost procedure is not standardized. • The number of implants, fractions, doses and imaging differ in literatur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e241555be0dbedb8ff97b894cac2d8
https://doi.org/10.1016/j.ctro.2021.10.005
https://doi.org/10.1016/j.ctro.2021.10.005
Autor:
Jae H. Choi, Kate Skehan, Jason Dowling, Helen Warren-Forward, Laura M. O'Connor, Peter B. Greer, Jarad Martin, John Simpson
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 20, Iss, Pp 34-39 (2021)
Physics and Imaging in Radiation Oncology
Physics and Imaging in Radiation Oncology
Background and purpose Magnetic resonance imaging (MRI)-only treatment planning is gaining in popularity in radiation oncology, with various methods available to generate a synthetic computed tomography (sCT) for this purpose. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f64987cccf33f1799aa2f9565b8871
http://www.sciencedirect.com/science/article/pii/S2405631621000592
http://www.sciencedirect.com/science/article/pii/S2405631621000592
Autor:
Tom Haswell, Matthew G Krebs, Chris J. Twelves, Katrina Walker, Corinne Faivre-Finn, David Sebag-Montefoire, Paul Shaw, Ahmed Salem, Nicola L. Hannaway, Anthony J. Chalmers, Alexandra Gilbert, R. Young, Geraldine Murden, Crispin T. Hiley, Sarah Brown, Jamie B. Oughton, Gerard G Hanna, Anderson J. Ryan, Rachel Phillip, Alastair Greystoke, Fiona Collinson, Kevin Franks, Martin Forster, Gerard Walls, Stephen Harrow, Samantha Hinsley
Publikováno v:
Walls, G M, Oughton, J B, Chalmers, A J, Brown, S, Collinson, F, Forster, M D, Franks, K N, Gilbert, A, Hanna, G G, Hannaway, N, Harrow, S, Haswell, T, Hiley, C T, Hinsley, S, Krebs, M, Murden, G, Phillip, R, Ryan, A J, Salem, A, Sebag-Montefoire, D, Shaw, P, Twelves, C J, Walker, K, Young, R J, Faivre-Finn, C & Greystoke, A 2020, ' CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer ', Clinical and translational radiation oncology, vol. 25, pp. 61-66 . https://doi.org/10.1016/j.ctro.2020.09.006
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 25, Iss, Pp 61-66 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 25, Iss, Pp 61-66 (2020)
Highlights • Lung cancer is the leading cause of cancer mortality worldwide. • Gold standard chemoradiotherapy is not deliverable for the majority of patients. • Radiation-induced DNA damage repair is an actionable mechanism of radioresistance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab793db3c955a860dc79fcb06479e299
https://pure.qub.ac.uk/en/publications/concorde-a-phase-i-platform-study-of-novel-agents-in-combination-with-conventional-radiotherapy-in-nonsmallcell-lung-cancer(7a8b2ae9-083a-4970-a3aa-cc71031461f1).html
https://pure.qub.ac.uk/en/publications/concorde-a-phase-i-platform-study-of-novel-agents-in-combination-with-conventional-radiotherapy-in-nonsmallcell-lung-cancer(7a8b2ae9-083a-4970-a3aa-cc71031461f1).html
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 19, Iss, Pp 87-95 (2019)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Majority of DARS investigated for radiation-induced late dysphagia in HNC. • Epiglottis (E) and submandibular glands (SG) have previously not been reported as critical for dysphagia. • Reduced epiglottic inversion may explain the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60649258ff239832128ffe561e1bd58
https://pubmed.ncbi.nlm.nih.gov/31646203
https://pubmed.ncbi.nlm.nih.gov/31646203
Autor:
le Guyader M; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Lam Cham Kee D; Department of Radiation Oncology, Pôle Santé République, Clermont-Ferrand, France., Thamphya B; Department of Statistics, Antoine Lacassagne Cancer Center, University of Côte d'Azur, Nice, France., Schiappa R; Department of Statistics, Antoine Lacassagne Cancer Center, University of Côte d'Azur, Nice, France., Gautier M; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Chand-Fouche ME; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Hannoun-Levi JM; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2021 Nov 06; Vol. 32, pp. 15-23. Date of Electronic Publication: 2021 Nov 06 (Print Publication: 2022).
Autor:
O'Connor LM; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia.; School of Health Sciences, University of Newcastle, Newcastle, NSW, Australia., Skehan K; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia., Choi JH; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Simpson J; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia.; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Martin J; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia.; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Warren-Forward H; School of Health Sciences, University of Newcastle, Newcastle, NSW, Australia., Dowling J; School of Mathematical and Physical Sciences, University of Newcastle, Newcastle, NSW, Australia.; Australian E-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Herston, QLD, Australia., Greer P; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia.; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Publikováno v:
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2021 Oct 16; Vol. 20, pp. 34-39. Date of Electronic Publication: 2021 Oct 16 (Print Publication: 2021).
Autor:
Walls GM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland, UK., Oughton JB; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Chalmers AJ; Institute of Cancer Sciences, University of Glasgow, Scotland, UK., Brown S; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Collinson F; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Forster MD; Department of Oncology, UCL Cancer Institute, England, UK., Franks KN; St James' Institute of Oncology, University of Leeds, England, UK., Gilbert A; St James' Institute of Oncology, University of Leeds, England, UK., Hanna GG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia., Hannaway N; Newcastle University, Newcastle upon Tyne, England, UK., Harrow S; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK., Haswell T; Patient and Public Involvement Advocacy, UK., Hiley CT; Department of Oncology, UCL Cancer Institute, England, UK., Hinsley S; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.; Institute of Cancer Sciences, University of Glasgow, Scotland, UK., Krebs M; Faculty of Biology, Medicine and Health, University of Manchester, England, UK., Murden G; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Phillip R; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Ryan AJ; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, England, UK., Salem A; The Christie NHS Foundation Trust/University of Manchester, Manchester, England, UK., Sebag-Montefoire D; St James' Institute of Oncology, University of Leeds, England, UK., Shaw P; Velindre University NHS Trust, Cardiff, Wales, UK., Twelves CJ; St James' Institute of Oncology, University of Leeds, England, UK., Walker K; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK., Young RJ; Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, England, UK., Faivre-Finn C; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, England, UK., Greystoke A; Newcastle University, Newcastle upon Tyne, England, UK.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2020 Sep 22; Vol. 25, pp. 61-66. Date of Electronic Publication: 2020 Sep 22 (Print Publication: 2020).
Autor:
Hedström J; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, 413 45 Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Anesthesia and Intensive Care, Area 2, 416 85 Gothenburg, Sweden., Tuomi L; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, 413 45 Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Otorhinolaryngology, 413 45 Gothenburg, Sweden., Finizia C; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, 413 45 Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Otorhinolaryngology, 413 45 Gothenburg, Sweden., Olsson C; Department of Radiation Physics, Institute of Clinical Sciences, the Sahlgrenska Academy Gothenburg University, 413 45 Gothenburg, Sweden.; Regional Cancer Center West, the Western Sweden Healthcare Region, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2019 Aug 30; Vol. 19, pp. 87-95. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).
Autor:
Esteyrie V; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Gleyzolle B; Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Lusque A; Biostatistics Unit, Institut Claudius Regaud-, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France., Graff P; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Modesto A; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Rives M; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Lapeyre M; Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Desrousseaux J; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Graulières E; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Hangard G; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Arnaud FX; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Ferrand R; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Delord JP; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Poublanc M; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Mounier M; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Filleron T; Biostatistics Unit, Institut Claudius Regaud-, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France., Laprie A; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2019 Mar 09; Vol. 16, pp. 34-39. Date of Electronic Publication: 2019 Mar 09 (Print Publication: 2019).